文献速递消化内镜消化道出血

结直肠内镜黏膜下剥离术后直接口服抗凝药恢复时机:日本全国性研究

Timing of Direct Oral Anticoagulants Resumption Following Colorectal Endoscopic Submucosal Dissection: A Nationwide Study in Japan.
PubMed 文献 · Am J Gastroenterol · 2024-08-23

该回顾性队列研究利用日本全国数据库2012至2023年数据,纳入3550例结直肠内镜黏膜下剥离术后恢复直接口服抗凝药(DOAC)的患者,比较术后次日恢复(早期组)与术后2至3天恢复(延迟组)的30天延迟出血和血栓栓塞事件。经逆概率治疗加权调整后,早期组延迟出血风险未显著增加(OR 1.05;95%CI 0.78-1.42;P=0.73),但血栓栓塞事件风险显著降低(OR 0.45;95%CI 0.25-0.82;P<0.01)。

要点

  • 结直肠ESD术后次日恢复DOAC未显著增加延迟出血风险(OR 1.05;95%CI 0.78-1.42;P=0.73)。
  • 结直肠ESD术后次日恢复DOAC显著降低血栓栓塞事件风险(OR 0.45;95%CI 0.25-0.82;P<0.01)。
  • 研究基于日本全国数据库3550例DOAC使用者,早期恢复2698例(76%),延迟恢复852例(24%)。

核心结论

  • 结直肠ESD术后次日恢复DOAC与血栓栓塞事件减少相关,且未显著增加延迟出血风险。

研究设计与样本

  • 回顾性队列研究,使用日本诊断程序组合数据库2012至2023年数据,纳入结直肠ESD后3天内恢复DOAC的患者,排除使用其他抗凝药者,分为早期恢复组(ESD次日)和延迟恢复组(ESD后2至3天),采用逆概率治疗加权比较30天内延迟出血和血栓栓塞事件。

主要发现

  • 共176139例结直肠ESD中,3550例涉及DOAC使用者,其中早期恢复组2698例(76%),延迟恢复组852例(24%)。
  • 逆概率治疗加权调整后,早期恢复组较延迟恢复组延迟出血风险未显著增加(OR 1.05;95%CI 0.78-1.42;P=0.73)。
  • 早期恢复组较延迟恢复组血栓栓塞事件风险显著降低(OR 0.45;95%CI 0.25-0.82;P<0.01)。

关键数值与推荐

  • 延迟出血定义为ESD后需内镜下止血或输血的出血。
  • 仅纳入ESD后3天内恢复DOAC的患者。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: With the increasing use of direct oral anticoagulants (DOACs), managing these agents around endoscopic submucosal dissection (ESD) is crucial. However, due to the need for a large number of cases, studies examining the timing of resumption are lacking, resulting in varied recommendations across international guidelines. We aimed to perform a comparative study about the resumption timing of DOACs after colorectal ESD using a nationwide database in Japan. METHODS: We conducted a retrospective cohort study on colorectal ESD using the Diagnosis Procedure Combination database from 2012 to 2023. Patients using anticoagulants other than DOACs were excluded, and only those who resumed DOACs within 3 days were included. From eligible patients, we divided them into early (the day after ESD) and delayed (2-3 days after ESD) resumption groups. We used inverse probability of treatment weighting to assess the delayed bleeding and thromboembolic events within 30 days. Delayed bleeding was defined as bleeding requiring endoscopic hemostasis or blood transfusion after ESD. RESULTS: Of 176,139 colorectal ESDs, 3,550 involved DOAC users, with 2,698 (76%) categorized as early resumption and 852 (24%) categorized as delayed resumption groups. After inverse probability of treatment weighting adjustment, the early resumption group did not significantly increase delayed bleeding compared with the delayed resumption group (odds ratio 1.05; 95% confidence interval 0.78-1.42; P = 0.73). However, it significantly reduced the risk of thromboembolic events (odds ratio 0.45; 95% confidence interval 0.25-0.82; P < 0.01). DISCUSSION: Resuming DOACs the day after colorectal ESD was associated with reduced thromboembolic events without significant increase in risk of delayed bleeding.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Ichita C, Goto T, Fushimi K, et al. Timing of Direct Oral Anticoagulants Resumption Following Colorectal Endoscopic Submucosal Dissection: A Nationwide Study in Japan. Am J Gastroenterol. 2024. PMID: 39177332. doi:10.14309/ajg.0000000000003050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。